US Insurer United Rewards Amgen’s Early Entry With Bevacizumab And Trastuzumab

 
• By Aidan Fry
  
United_Healthcare
Major US health insurer UnitedHealthcare will soon prefer Amgen's becacizumab and trastuzumab biosimilars • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products